Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ioTech International is a U.S.-based healthcare company focused on patented stabilized molecular iodine technology for oral care, sinus/ENT hygiene, hand cleansing, and related wellness applications. The company markets commercially available products under the ioRinse and related brands, positioning them as clinically tested, microbiome-friendly, broad-spectrum antimicrobial formulations for professional and consumer use. Its core business appears to center on dental and oral-health products rather than prescription therapeutics, with use cases including bad breath, periodontal maintenance, oral irritation, mucositis support, and peri-implant care. ioTech also states that it is expanding applications of its molecular iodine platform into veterinary and agricultural settings. The company operates as a private, active healthcare products business rather than a classic drug-development biotech with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ioTech International.